# Study Evaluating Vaccine in Adults With HIV

> **NCT00195234** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 60 (—)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** HIV CTL MEP 1000 micrograms, 19 months per subject

## Key facts

- **NCT ID:** NCT00195234
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 60 (—)
- **Last updated:** 2007-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195234, "Study Evaluating Vaccine in Adults With HIV". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00195234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*